» Articles » PMID: 8942867

The Role of Postoperative Irradiation in the Management of Sphenoid Wing Meningiomas. A Preliminary Report

Overview
Journal Ophthalmology
Publisher Elsevier
Specialty Ophthalmology
Date 1996 Nov 1
PMID 8942867
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To determine whether postoperative radiation therapy decreases recurrence rates in subtotally excised and recurrent sphenoid wing meningiomas.

Methods: Patients with primary subtotally excised and recurrent sphenoid wing meningiomas who underwent surgery between 1981 and 1994 (n = 105) were prospectively followed for recurrence. Postoperative radiation was not recommended in patients who had complete excision; therefore, their recurrence rates were not evaluated in this study. Patients with malignant meningiomas also were excluded from analysis. Recurrence was defined as evidence of tumor growth on neuroimaging with or without clinical symptoms.

Results: Follow-up information was available for 86 patients; 69 had primary subtotally excised tumors and 17 had recurrent tumors. Follow-up information was unavailable in the remaining 19 patients. Tumor location and histopathology, type of surgery performed, and patient sex and age were similar in the irradiated and nonirradiated subgroups. Postoperative irradiation was delivered to 31 patients with primary tumors and 11 with recurrent tumors; none of these 42 patients had recurrence during a mean observation period of 4.2 and 3.5 years, respectively. The nonirradiated group consisted of 38 patients with primary tumors and 6 with recurrent tumors; 16 of 18 patients who had primary meningiomas had a recurrence and 5 of 6 who had recurrent tumors had another relapse (mean interval between resection and recurrence, 4.4 years and 14 months, respectively).

Conclusions: Postoperative radiation appeared to delay recurrence in subtotally excised and recurrent sphenoid wing meningiomas during the time frame of this study.

Citing Articles

The management of symptomatic hyperostotic bilateral spheno-orbital meningiomas: patient series.

Harris L, Bal J, Drosos E, Matloob S, Roberts N, Hammerbeck-Ward C J Neurosurg Case Lessons. 2023; 6(13).

PMID: 37773763 PMC: 10555579. DOI: 10.3171/CASE23179.


En Plaque Meningiomas: A Narrative Review.

Elder T, Yokoi H, Chugh A, Lagman C, Wu O, Wright C J Neurol Surg B Skull Base. 2021; 82(Suppl 3):e33-e44.

PMID: 34306915 PMC: 8289553. DOI: 10.1055/s-0039-3402012.


[Ga]-DOTATATE PET/MRI as an adjunct imaging modality for radiation treatment planning of meningiomas.

Mahase S, OBrien D, No D, Roytman M, Skafida M, Lin E Neurooncol Adv. 2021; 3(1):vdab012.

PMID: 33738446 PMC: 7954102. DOI: 10.1093/noajnl/vdab012.


High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539.

Rogers C, Won M, Vogelbaum M, Perry A, Ashby L, Modi J Int J Radiat Oncol Biol Phys. 2019; 106(4):790-799.

PMID: 31786276 PMC: 7117785. DOI: 10.1016/j.ijrobp.2019.11.028.


Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.

Rogers L, Zhang P, Vogelbaum M, Perry A, Ashby L, Modi J J Neurosurg. 2017; 129(1):35-47.

PMID: 28984517 PMC: 5889346. DOI: 10.3171/2016.11.JNS161170.